Amdocs recently revised its FY23 outlook, raising reported revenue growth to 5.0%-9.0% and non-GAAP diluted EPS growth to 9.0%-13.0%, while reiterating FCF of ~$700 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results